MRNA Latest Quarter's Earnings
Announce Date 05/02/2024
EPS Normalized Actual $0.55 (Beat by $4.14)
EPS GAAP Actual $0.55 (Beat by $4.14)
Revenue Actual $6.066B
Revenue Surprise Beat by $6066M
Upcoming Quarter's Earnings
Announce Date 06/30/2024 (Pre-Market)
EPS Normalized Estimate $1.33835
EPS GAAP Estimate $1.33835
Revenue Estimate $3.20425B
Annual EPS Estimate
Fiscal Period Ending EPS Estimate Forward PE Low High # of Analysts
Dec 2028 14.666 8.38 11.08621 19.20441 7
Dec 2027 3.00324 40.9 2.27019 3.9326 6
Quarterly EPS History
Period EPS Beat / Miss Revenue YoY Beat / Miss
FQ1 2022 (Mar 2022) 9.09 9.09 6.066B 68.07% 6066M
FQ4 2021 (Dec 2021) 12.03 12.03 7.211B 92.09% 7211M
FQ3 2021 (Sep 2021) 8.27 8.27 4.969B 96.82% 4969M
FQ2 2021 (Jun 2021) 6.93 6.93 4.354B 98.48% 4354M
FQ1 2021 (Mar 2021) 3.05 3.05 1.937B 99.57% 1937M
FQ4 2020 (Dec 2020) -0.69 -0.69 0.570745B 97.54% 570.75M
FQ3 2020 (Sep 2020) -0.59 -0.59 0.15791B 89.21% 157.91M
FQ2 2020 (Jun 2020) -0.31 -0.31 0.066351B 80.28% 66.35M
Quarterly Estimates Summary

FQ4 Announce Date

06/30/2024 (Pre-Market)

Consensus EPS Estimates

1.33835

Consensus Revenue Estimates

3.20425B

Consensus EPS Estimates
Fiscal Period Ending EPS Estimate YoY Growth(%) Low High # of Analysts
FQ4 2026 (Oct 2026) 1.7809 -- 0.55294 2.60566 5
FQ3 2026 (Jul 2026) -2.7373 -- -4.00499 -0.84988 5
FQ1 2026 (Mar 2026) -2.6996 -- -3.94983 -0.83817 11
FQ4 2025 (Oct 2025) -0.51023 -- -0.74653 -0.15842 11
FQ3 2025 (Jul 2025) -2.78108 -- -4.06904 -0.86347 10
FQ2 2025 (Jun 2025) -2.71443 -- -13.07914 0.44894 6
FQ1 2025 (Mar 2025) -2.54878 -- -12.28097 0.42155 6
FQ4 2024 (Oct 2024) -1.12396 -- -1.9201 0.19669 13
FQ3 2024 (Jul 2024) -3.40993 -- -4.16554 -2.82869 13
FQ2 2024 (Jun 2024) 1.33835 -- -0.66462 4.46117 13
Consensus Revenue Estimates
Fiscal Period Ending Revenue Estimate YoY Growth(%) Low High # of Analysts
FQ4 2026 (Oct 2026) 3.19B -- 1.5B 4.33B 10
FQ3 2026 (Jul 2026) 0.32B -- 0.15B 0.43B 10
FQ1 2026 (Mar 2026) 0.35B -- 0.16B 0.47B 10
FQ4 2025 (Oct 2025) 1.71B -- 0.8B 2.32B 5
FQ3 2025 (Jul 2025) 0.37B -- 0.18B 0.51B 5
FQ2 2025 (Jun 2025) 0.5B -- 0.05B 1.98B 4
FQ1 2025 (Mar 2025) 0.63B -- 0.07B 2.49B 4
FQ4 2024 (Oct 2024) 1.49B -- 0.96B 1.91B 12
FQ3 2024 (Jul 2024) 0.12B -- 0.07B 0.18B 11
FQ2 2024 (Jun 2024) 3.2B -- 2.57B 3.82B 18
Quarterly Estimates Revisions

EPS # of Up Revisions

4

EPS # of Down Revisions

4

Revenue # of Up Revisions

6

Revenue # of Down Revisions

3

Consensus EPS Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Consensus Revenue Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Earnings Surprise Summary

EPS # of Beats

5

EPS # of Misses

3

EPS # of in-lines

0

Revenue # of Beats

8

Revenue # of Misses

0

Revenue # of in-lines

0

Earnings Surprise (EPS) - Actual vs Consensus
Earnings Date EPS Estimate EPS Actual Surprise Surprise %
FQ1 2022 (Mar 2022) 9.09 9.09 100%
FQ4 2021 (Dec 2021) 12.03 12.03 100%
FQ3 2021 (Sep 2021) 8.27 8.27 100%
FQ2 2021 (Jun 2021) 6.93 6.93 100%
FQ1 2021 (Mar 2021) 3.05 3.05 100%
FQ4 2020 (Dec 2020) -0.69 -0.69 100%
FQ3 2020 (Sep 2020) -0.59 -0.59 100%
FQ2 2020 (Jun 2020) -0.31 -0.31 100%
Revenue Surprise - Actual vs Consensus
Earnings Date Revenue Estimate Revenue Actual Surprise Surprise %
FQ1 2022 (Mar 2022) $0B $6.07B $6066M 100%
FQ4 2021 (Dec 2021) $0B $7.21B $7211M 100%
FQ3 2021 (Sep 2021) $0B $4.97B $4969M 100%
FQ2 2021 (Jun 2021) $0B $4.35B $4354M 100%
FQ1 2021 (Mar 2021) $0B $1.94B $1937M 100%
FQ4 2020 (Dec 2020) $0B $0.57B $570.75M 100%
FQ3 2020 (Sep 2020) $0B $0.16B $157.91M 100%
FQ2 2020 (Jun 2020) $0B $0.07B $66.35M 100%
Unlock